Logo DoctorsConnect

Your medical data, safe and secure.

Name

Isosorbide Mononitrate

Description

Isosorbide mononitrate is a drug used principally in the treatment of angina pectoris[1] and acts by dilating the blood vessels so as to reduce the blood pressure. It is sold by AstraZeneca under the trade name Imdur. Isosorbide mononitrate is used to for the the prophylactic treatment of angina pectoris; that is, it is taken in order to prevent or at least reduce the occurrence of angina. Research on Isosorbide mononitrate as a cervical ripener to reduce time at hospital to birth is supportive. Isosorbide mononitrate is an active metabolite of isosorbide dinitrate and exerts qualitatively similar effects. Isosorbide mononitrate reduces the workload of the heart by producing venous and arterial dilation. By reducing the end diastolic pressure and volume, isosorbide mononitrate lowers intramural pressure, hence leading to an improvement in the subendocardial blood flow. The net effect when administering isosorbide mononitrate is therefore a reduced workload for the heart and an improvement in the oxygen supply/demand balance of the myocardium. The adverse reactions which follow have been reported in studies with isosorbide mononitrate: Very common. Headache predominates (up to 30%) necessitating withdrawal of 2 to 3 % of patients, but the incidence reduces rapidly as treatment continues . Common. Tiredness, sleep disturbances (6%) and gastrointestinal disturbances (6%) have been reported during clinical trials with isosorbide mononitrate modified release tablets, but at a frequency no greater than for placebo. Hypotension (4 to 5%), poor appetite (2.5%), nausea (1%). Adverse effects associated with the clinical use of the drug are as expected with all nitrate preparations. They occur mainly in the early stages of treatment. Hypotension (4%) with symptoms such as dizziness and nausea (1%) have been reported. These symptoms generally disappear during long-term treatment. Other reactions that have been reported with isosorbide mononitrate modified release tablets include tachycardia, vomiting, diarrhoea, vertigo and heartburn

Brands

Company not known

Chemydur

Company not known

Corangin

Company not known

Dilatrate

Company not known

Duride

Company not known

Elantan

Company not known

Etimonis

Company not known

Imodur

Company not known

Imtrate

Company not known

Ismexin

Company not known

Ismo

Company not known

Ismox

Company not known

Isomon

Company not known

Isomonit

Company not known

Isonorm

Company not known

Medocor

Company not known

Monicor

Company not known

Monit

Company not known

Mono Corax

Company not known

Mono Mack

Company not known

Monocedocard

Company not known

Monoclair

Company not known

Monocord

Company not known

Monodur Durules

Company not known

Monolong

Company not known

Monomax

Company not known

Mononit

Company not known

Monopront

Company not known

Monosorb

Company not known

Monosordil

Company not known

Monotrate

Company not known

Nitramin

Company not known

Olicard

Company not known

Olicardin

Company not known

Orasorbil

Company not known

Pertil

Company not known

Plodin

Company not known

Promocard

Company not known

Sigacora

Company not known

Solotrate

Company not known

Sorbimon

Company not known

Turimonit

Company not known

Uniket

Company not known

Vasdilat